ARTICLE | Company News
Hisamitsu, Shionogi sales and marketing update
January 27, 2014 8:00 AM UTC
Hisamitsu's Noven Pharmaceuticals Inc. subsidiary and Shionogi will exclusively co-promote Brisdelle paroxetine in the U.S. The low-dose selective serotonin reuptake inhibitor (SSRI) is approved to ...